We are live on ! Find out more
APLM icon

Apollomics

12 hedge funds and large institutions have $8.54M invested in Apollomics in 2023 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 1

67% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 3

20% more funds holding

Funds holding: 1012 (+2)

1.89% less ownership

Funds ownership: 1.99%0.1% (-1.9%)

87% less capital invested

Capital invested by funds: $67.8M → $8.54M (-$59.2M)

Holders
12
Holders Change
+2
Holders Change %
+20%
% of All Funds
0.17%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
2
Reduced
1
Closed
3
Calls
Puts
Net Calls
Net Calls Change

APLM Hedge Fund Activity: Q4 2023 in Review

12 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Apollomics (APLM) for Q4 2023, worth a combined $8.54M — down 87% from $67.8M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new APLM positions and 3 closed out — a net gain of 2 holders — while 2 added to existing stakes and 1 trimmed.

The largest buyer was Citadel Advisors, opening a new position worth an estimated $67.3K. The largest seller was OrbiMed, cutting an estimated $11.6M.

  • 12 institutional investors held Apollomics (APLM) as of Q4 2023, up from 10 in Q3 2023.
  • Funds reported $8.54M of Apollomics stock for Q4 2023, down 87% quarter-over-quarter.
  • 5 funds opened new Apollomics positions in Q4 2023 and 3 closed out, a net change of +2 holders.
  • The largest Apollomics buyer in Q4 2023 was Citadel Advisors, an estimated $67.3K added.
  • The largest Apollomics seller in Q4 2023 was OrbiMed, an estimated $11.6M sold.

Based on aggregated 13F filings for Q4 2023.